These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3159548)

  • 1. Graft-vs.-host reactions: mechanisms and contemporary theories.
    Bril H; Benner R
    Crit Rev Clin Lab Sci; 1985; 22(1):43-95. PubMed ID: 3159548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases.
    Gleichmann E; Gleichmann H
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):115s-120s. PubMed ID: 3159804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The graft-versus-host reaction in chickens: determination of some parameters.
    Coudert F; Dambrine G; Cauchy L
    Ann Rech Vet; 1978; 9(1):33-41. PubMed ID: 30387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The host component of the popliteal lymph node graft-versus-host reaction. Selective representation of lymphocyte subsets and the requirement for alloantigenic incompatibility between donor cells and activated host B cells.
    Rolstad B; Fossum S; Hunt SV; Ford WL
    Scand J Immunol; 1986 May; 23(5):589-98. PubMed ID: 2939554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute graft-vs-host disease: pathobiology and management.
    Goker H; Haznedaroglu IC; Chao NJ
    Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma.
    Truitt RL; Shih CC; LeFever AV
    Transplantation; 1986 Mar; 41(3):301-10. PubMed ID: 3513389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease.
    Ghayur T; Seemayer TA; Kongshavn PA; Gartner JG; Lapp WS
    Transplantation; 1987 Aug; 44(2):261-7. PubMed ID: 3307050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of delayed type hypersensitivity to host histocompatibility antigens during graft-versus-host reactions.
    Benner R; Wolters EA; Bril H; Molendijk A; van Oudenaren A
    Immunol Rev; 1985 Dec; 88():25-57. PubMed ID: 2935486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST; Gleichmann H; Gleichmann E
    J Exp Med; 1984 Feb; 159(2):508-23. PubMed ID: 6229596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Graft vs host reaction and graft vs host diseases].
    Sakagami K; Orita K
    Nihon Rinsho; 1985 Jan; 43(1):97-103. PubMed ID: 3886972
    [No Abstract]   [Full Text] [Related]  

  • 15. Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice.
    Fukuzawa M; Via CS; Shearer GM
    J Immunol; 1988 Jul; 141(2):430-9. PubMed ID: 2968400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the graft-versus-host reaction by cyclophosphamide: dependence on timing of drug administration.
    Lehnert S; Rybka WB
    Bone Marrow Transplant; 1994 Apr; 13(4):473-7. PubMed ID: 8019473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal murine graft-versus-host disease in the absence of detectable cytotoxic T lymphocytes.
    Jadus MR; Peck AB
    Transplantation; 1983 Sep; 36(3):281-9. PubMed ID: 6604351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The popliteal lymph node graft-versus-host (GvH) reaction in the rat: a useful model for studying cell interactions in the immune response?
    Rolstad B
    Immunol Rev; 1985 Dec; 88():153-68. PubMed ID: 3910555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The graft-versus-host reaction and immune function. I. T helper cell immunodeficiency associated with graft-versus-host-induced thymic epithelial cell damage.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1984 Mar; 37(3):281-6. PubMed ID: 6230783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal lesions of the GVHR: evaluation of the role of different MHC and non MHC loci and of the Ly-2+ and L3T4+ T lymphocytes.
    Piguet PF; Janin-Mercier A; Vassalli P; Saurat JH
    J Immunol; 1987 Jul; 139(2):406-10. PubMed ID: 2955041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.